Sep. 8, 2022
NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference
NRx Pharmaceuticals, Inc. today announced its Chief Executive Officer, Stephen Willard, and other executive leaders will be presenting an update to the company’s business at the H.C. Wainwright & Co. 24th Annual Global Investment Conference.